- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
POMDOCTOR LIMITED American Depositary Shares(POM)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for POM
11/13/2026: POM (1-star) is currently NOT-A-BUY. Pass it for now.
PomDoctor Limited is a micro-cap digital healthcare and internet hospital company operating in China that connects patients to doctors and pharmaceutical supply chains. The company benefits from rising demand for chronic disease management and is advancing AI-enabled health solutions. However, it faces intense competition from dominant industry rivals, ongoing net losses, and high stock price volatility. The stock may suit speculative growth investors, while market participants should closely monitor its path to profitability, regulatory developments, and liquidity management.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While top-line revenue is expanding, persistent net losses make it a speculative fit for growth strategies. |
| Momentum investor | Strong fit while signal remains positive | Low market capitalization can generate sharp short-term price swings during positive news flows. |
| Value investor | Weak fit | Unprofitable operations and volatile market valuation prevent a traditional value appeal. |
| Dividend investor | Weak fit | The company pays no dividends and reinvests all capital into basic operations. |
| Low-risk investor | Weak fit | High equity volatility and regulatory risks create an elevated risk profile. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock experiences extreme price fluctuations driven by its micro-cap status and news cycles. |
| Valuation risk | High | Uncertain earnings visibility makes fundamental valuation challenging to anchor. |
| Competition risk (ecosystem giants like JD Health) | High | Well-capitalized competitors dominate market share and customer acquisition channels. |
| Business quality | Medium / high | Although digital health services address real needs, path-to-profitability metrics require validation. |
| Dividend income | Low / none | No cash distribution or yield is provided to shareholders. |
| Execution risk | High | Management must successfully execute its AI and data commercialization strategy while preserving liquidity. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 58.27M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 4.4M shares | Beta - | 52 Weeks Range 0.06 - 5.69 | Updated Date 11/14/2026 |
52 Weeks Range 0.06 - 5.69 | Updated Date 11/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -40.31 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Industry classification is unavailable for this snapshot.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -28.57% | Avg. Invested days 3 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Internet Hospital Services | Fees and service charges derived from online medical consultations, prescription renewals, and patient management. | Generates digital service income when patients interact with doctors online. |
| Pharmaceutical Supply Chain | Wholesale and retail sales of pharmaceutical products and supply chain platform operation services. | Acts as a distributor and online merchant selling medications to consumers and pharmacies. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 126.01M | Price to Sales(TTM) 0.14 |
Enterprise Value 126.01M | Price to Sales(TTM) 0.14 | ||
Enterprise Value to Revenue 2.05 | Enterprise Value to EBITDA - | Shares Outstanding 35.76M | Shares Floating 1.12M |
Shares Outstanding 35.76M | Shares Floating 1.12M | ||
Percent Insiders - | Percent Institutions 0.01 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

